General Atlantic Genpar (bermuda), L.P., 10% Owner at CinCor Pharma, Inc. (CINC), bought 1,700,000 shares at $16.00 ($27.2M) on 2022-01-11, disclosed to the SEC on 2022-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| ALKT | BUY | 2026-03-16 | $9.2M | — | Filing → |
| ALKT | BUY | 2026-03-11 | $50.6M | — | Filing → |
| ALKT | SELL | 2024-11-27 | $119.3M | — | Filing → |